Qin Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Qin Yang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Xiao-Qing Zhang
Department of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China
3 shared publications Yu-Hua Hao
Department of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China
3 shared publicationsHong-Yang Liu
Department of Heart Intensive Care Unit
2 shared publicationsLi-Peng Guo
Department of Cardiology
2 shared publicationsLu-Lu Xu
Department of Infection
2 shared publicationsSi-Xu Liu
Department of Internal Medicine, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China
2 shared publications
Latest Publications
- Open Access
- 7 September 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (9)
Effect of thymoquinone on sepsis-induced cardiac damage via anti-inflammatory and anti-apoptotic mechanisms
Objective: Sepsis is a systemic and deleterious host reaction to severe infection. Cardiac dysfunction is an established serious outcome of multiorgan failure associated with this condition. Therefore, it is important to develop drugs targeting sepsis-induced cardiac damage and inflammation. Thymoquinone (TQ) has anti-inflammatory, anti-oxidant, anti-fibrotic, anti-tumor, and anti-apoptotic effects. This study examined the effects of thymoquinone on sepsis-induced cardiac damage. Methods: Male BALB/c mice were randomly segregated into four groups: control, TQ, cecal ligation and puncture (CLP), and CLP + TQ groups. CLP was performed after gavaging the mice with TQ for 2 weeks. After 48 hours, we estimated the histopathological changes in the cardiac tissue and the serum levels of cardiac troponin-T. We evaluated the expression of factors associated with inflammation, apoptosis, oxidative stress, and the PI3K/AKT pathway. Results: TQ significantly reduced intestinal histological alterations and inhibited the upregulation of interleukin-6, tumor necrosis factor-α, Bax, NOX4, p-PI3K, and p-AKT. TQ also increased Bcl-2, HO-1, and NRF2 expression. Conclusion: These results suggest that TQ effectively modulates pro-inflammatory, apoptotic, oxidative stress, and PI3K/AKT pathways, making it indispensable in the treatment of sepsis-induced cardiac damage.
- 7 September 2022
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 50 (9)
Open AccessEffect of thymoquinone on sepsis-induced cardiac damage via anti-inflammatory and anti-apoptotic mechanisms
Objective: Sepsis is a systemic and deleterious host reaction to severe infection. Cardiac dysfunction is an established serious outcome of multiorgan failure associated with this condition. Therefore, it is important to develop drugs targeting sepsis-induced cardiac damage and inflammation. Thymoquinone (TQ) has anti-inflammatory, anti-oxidant, anti-fibrotic, anti-tumor, and anti-apoptotic effects. This study examined the effects of thymoquinone on sepsis-induced cardiac damage. Methods: Male BALB/c mice were randomly segregated into four groups: control, TQ, cecal ligation and puncture (CLP), and CLP + TQ groups. CLP was performed after gavaging the mice with TQ for 2 weeks. After 48 hours, we estimated the histopathological changes in the cardiac tissue and the serum levels of cardiac troponin-T. We evaluated the expression of factors associated with inflammation, apoptosis, oxidative stress, and the PI3K/AKT pathway. Results: TQ significantly reduced intestinal histological alterations and inhibited the upregulation of interleukin-6, tumor necrosis factor-α, Bax, NOX4, p-PI3K, and p-AKT. TQ also increased Bcl-2, HO-1, and NRF2 expression. Conclusion: These results suggest that TQ effectively modulates pro-inflammatory, apoptotic, oxidative stress, and PI3K/AKT pathways, making it indispensable in the treatment of sepsis-induced cardiac damage.
- Open Access
- 23 March 2021
- Published by Springer Nature in Research Square
Protective Role of Thymoquinone in Hyperlipidemia-Induced Liver Injury in LDL-R-/- Mice
Background: Hyperlipidemia, a heterogeneous group of disorders characterized by elevated levels of plasma lipids, causes serious health problems and can lead to fatty liver and nonalcoholic fatty liver disease. Thymoquinone (TQ), a major active component of Nigella sativa, can exert a vast array of biological effects. Various studies have reported that TQ protects against liver injury, and we previously reported that TQ reduces cardiac damage in mice fed a high-cholesterol diet (HD). However, few studies have evaluated the effects of TQ on hyperlipidemia-induced liver injury. The aim of this study was to investigate the possible protective effects of TQ against liver injury in hyperlipidemia-induced LDL-R-/- mice.Methods: Eight-week-old male LDL-R-/- mice were randomly divided into three groups based on diet: normal diet (ND group, which was the control), high cholesterol diet (HD group), and HD mixed with TQ (HD + TQ group). All mice were fed for 8 weeks. Blood samples were obtained from the inferior vena cava, collected in serum tubes, and stored at −80 °C to investigate the serum lipoprotein profile. Longitudinal sections of liver tissues were fixed in 10% formalin and embedded in paraffin for histological evaluation. The remainder of the liver tissues was snap-frozen in liquid nitrogen for mRNA and immunoblotting analyses.Results: TQ administration significantly reduced liver histological alterations caused by hyperlipidemia. TQ mitigated hyperlipidemia-induced liver injury, as indicated by the suppression of increases in metabolic parameters (total cholesterol, triglyceride, and low-density lipoprotein-cholesterol), hepatic biochemical parameters (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase), pyroptosis indicators (nucleotide-binding oligomerization domain-like receptor 3, interleukin [IL]-1β, and IL-18), a macrophage marker (CD68-positive cells), and phosphatidylinositide 3-kinase levels induced by the HD.Conclusions: These results indicate that TQ is a potential therapeutic agent for liver injury caused by hyperlipidemia.
- 23 March 2021
- Published by Springer Nature in Research Square
Open AccessProtective Role of Thymoquinone in Hyperlipidemia-Induced Liver Injury in LDL-R-/- Mice
Background: Hyperlipidemia, a heterogeneous group of disorders characterized by elevated levels of plasma lipids, causes serious health problems and can lead to fatty liver and nonalcoholic fatty liver disease. Thymoquinone (TQ), a major active component of Nigella sativa, can exert a vast array of biological effects. Various studies have reported that TQ protects against liver injury, and we previously reported that TQ reduces cardiac damage in mice fed a high-cholesterol diet (HD). However, few studies have evaluated the effects of TQ on hyperlipidemia-induced liver injury. The aim of this study was to investigate the possible protective effects of TQ against liver injury in hyperlipidemia-induced LDL-R-/- mice.Methods: Eight-week-old male LDL-R-/- mice were randomly divided into three groups based on diet: normal diet (ND group, which was the control), high cholesterol diet (HD group), and HD mixed with TQ (HD + TQ group). All mice were fed for 8 weeks. Blood samples were obtained from the inferior vena cava, collected in serum tubes, and stored at −80 °C to investigate the serum lipoprotein profile. Longitudinal sections of liver tissues were fixed in 10% formalin and embedded in paraffin for histological evaluation. The remainder of the liver tissues was snap-frozen in liquid nitrogen for mRNA and immunoblotting analyses.Results: TQ administration significantly reduced liver histological alterations caused by hyperlipidemia. TQ mitigated hyperlipidemia-induced liver injury, as indicated by the suppression of increases in metabolic parameters (total cholesterol, triglyceride, and low-density lipoprotein-cholesterol), hepatic biochemical parameters (alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase), pyroptosis indicators (nucleotide-binding oligomerization domain-like receptor 3, interleukin [IL]-1β, and IL-18), a macrophage marker (CD68-positive cells), and phosphatidylinositide 3-kinase levels induced by the HD.Conclusions: These results indicate that TQ is a potential therapeutic agent for liver injury caused by hyperlipidemia.
- Open Access
- 7 January 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (6) , e14011
A case report of rhabdomyolysis caused by the use of roxadustat in the treatment caused by renal anaemia
Case presentation: In this case, we share a case of one of our patients developed rhabdomyolysis after he was administered roxadustat to treat anaemia caused by chronic renal failure.Discussion: More than 1.2 million people died from chronic kidney damage (CKD) globally, in 2017. Anaemia is a common complication of CKD. Roxadustat is an oral hypoxia‐inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and regulates iron metabolism. Roxadustat is often used to treat anaemia caused by renal failure. Its adverse effects include high blood pressure, myocardial infarction, heart failure, high potassium, and dizziness; however, there are no reports about rhabdomyolysis associated with roxadustat.Conclusion: Physicians should be alert about the occurrence of rhabdomyolysis when roxadustat is used.
- 7 January 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (6) , e14011
Open AccessA case report of rhabdomyolysis caused by the use of roxadustat in the treatment caused by renal anaemia
Case presentation: In this case, we share a case of one of our patients developed rhabdomyolysis after he was administered roxadustat to treat anaemia caused by chronic renal failure.Discussion: More than 1.2 million people died from chronic kidney damage (CKD) globally, in 2017. Anaemia is a common complication of CKD. Roxadustat is an oral hypoxia‐inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis and regulates iron metabolism. Roxadustat is often used to treat anaemia caused by renal failure. Its adverse effects include high blood pressure, myocardial infarction, heart failure, high potassium, and dizziness; however, there are no reports about rhabdomyolysis associated with roxadustat.Conclusion: Physicians should be alert about the occurrence of rhabdomyolysis when roxadustat is used.
- Open Access
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 5512518
The Role of Exercise in Reducing Hyperlipidemia‐Induced Neuronal Damage in Apolipoprotein E‐Deficient Mice
Hyperlipidemia causes nervous system‐related diseases. Exercise training has developed into an established evidence‐based treatment strategy that is beneficial for neuronal injury. This study investigated the effect of exercise on hyperlipidemia‐induced neuronal injury in apolipoprotein E‐deficient (ApoE-/-) mice. Male ApoE-/- mice (age: 8 weeks) were randomly divided into four groups as follows: mice fed a normal diet (ND), normal diet+swimming training (ND+S), high‐fat diet (HD), and high‐fat diet+swimming (HD+S). Exercise training consisted of swimming for 40 min/day, 5 days/week for 12 weeks. After 12 weeks, we measured serum levels of total cholesterol (TC), triglyceride (TG), and low‐density lipoprotein cholesterol (LDL‐c). We also evaluated glial fibrillary acidic protein (GFAP) expression levels using immunohistochemistry, real‐time PCR, and immunoblotting. In addition, NLR family pyrin domain‐containing 3 (NLRP3), interleukin‐ (IL‐) 18, caspase‐1, Bax, Bcl‐2, and phosphorylated extracellular signal‐regulated kinase (p‐ERK) expression levels were measured using immunoblotting. Serum levels of TG, TC, and LDL‐c were lower in ApoE-/- HD+S mice than in ApoE-/- HD mice. Immunohistochemistry, real‐time PCR, and immunoblotting showed increased levels of GFAP in the ApoE-/- HD group. Immunoblotting revealed increased levels of NLRP3, IL‐18, caspase‐1, Bax, Bcl‐2, and p‐ERK in the ApoE-/- HD group; however, they were significantly suppressed in the ApoE-/- HD+S group. Therefore, exercise has protective effects against neuronal injury caused by hyperlipidemia.
- 1 January 2021
- Published by Wiley in BioMed Research International
- Vol. 2021 (1) , 5512518
Open AccessThe Role of Exercise in Reducing Hyperlipidemia‐Induced Neuronal Damage in Apolipoprotein E‐Deficient Mice
Hyperlipidemia causes nervous system‐related diseases. Exercise training has developed into an established evidence‐based treatment strategy that is beneficial for neuronal injury. This study investigated the effect of exercise on hyperlipidemia‐induced neuronal injury in apolipoprotein E‐deficient (ApoE-/-) mice. Male ApoE-/- mice (age: 8 weeks) were randomly divided into four groups as follows: mice fed a normal diet (ND), normal diet+swimming training (ND+S), high‐fat diet (HD), and high‐fat diet+swimming (HD+S). Exercise training consisted of swimming for 40 min/day, 5 days/week for 12 weeks. After 12 weeks, we measured serum levels of total cholesterol (TC), triglyceride (TG), and low‐density lipoprotein cholesterol (LDL‐c). We also evaluated glial fibrillary acidic protein (GFAP) expression levels using immunohistochemistry, real‐time PCR, and immunoblotting. In addition, NLR family pyrin domain‐containing 3 (NLRP3), interleukin‐ (IL‐) 18, caspase‐1, Bax, Bcl‐2, and phosphorylated extracellular signal‐regulated kinase (p‐ERK) expression levels were measured using immunoblotting. Serum levels of TG, TC, and LDL‐c were lower in ApoE-/- HD+S mice than in ApoE-/- HD mice. Immunohistochemistry, real‐time PCR, and immunoblotting showed increased levels of GFAP in the ApoE-/- HD group. Immunoblotting revealed increased levels of NLRP3, IL‐18, caspase‐1, Bax, Bcl‐2, and p‐ERK in the ApoE-/- HD group; however, they were significantly suppressed in the ApoE-/- HD+S group. Therefore, exercise has protective effects against neuronal injury caused by hyperlipidemia.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Protective Role of Coenzyme Q10 in Acute Sepsis‐Induced Liver Injury in BALB/c Mice
Sepsis increases the risk of the liver injury development. According to the research works, coenzyme Q10 exhibits hepatoprotective properties in vivo as well as in vitro. Current work aimed at investigating the protective impacts of coenzyme Q10 against liver injury in septic BALB/c mice. The male BALB/c mice were randomly segregated into 4 groups: the control group, the coenzyme Q10 treatment group, the puncture and cecal ligation group, and the coenzyme Q10+cecal ligation and puncture group. Cecal ligation and puncture was conducted after gavagaging the mice with coenzyme Q10 during two weeks. Following 48 h postcecal ligation and puncture, we estimated hepatic biochemical parameters and histopathological changes in hepatic tissue. We evaluated the expression of factors associated with autophagy, pyroptosis, and inflammation. Findings indicated that coenzyme Q10 decreased the plasma levels in alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase in the cecal ligation and puncture group. Coenzyme Q10 significantly inhibited the elevation of sequestosome‐1, interleukin‐1β, oligomerization domain‐like receptor 3 and nucleotide‐binding, interleukin‐6, and tumor necrosis factor‐α expression levels; coenzyme Q10 also increased beclin 1 levels. Coenzyme Q10 might be a significant agent in the treatment of liver injury induced by sepsis.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Open AccessProtective Role of Coenzyme Q10 in Acute Sepsis‐Induced Liver Injury in BALB/c Mice
Sepsis increases the risk of the liver injury development. According to the research works, coenzyme Q10 exhibits hepatoprotective properties in vivo as well as in vitro. Current work aimed at investigating the protective impacts of coenzyme Q10 against liver injury in septic BALB/c mice. The male BALB/c mice were randomly segregated into 4 groups: the control group, the coenzyme Q10 treatment group, the puncture and cecal ligation group, and the coenzyme Q10+cecal ligation and puncture group. Cecal ligation and puncture was conducted after gavagaging the mice with coenzyme Q10 during two weeks. Following 48 h postcecal ligation and puncture, we estimated hepatic biochemical parameters and histopathological changes in hepatic tissue. We evaluated the expression of factors associated with autophagy, pyroptosis, and inflammation. Findings indicated that coenzyme Q10 decreased the plasma levels in alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase in the cecal ligation and puncture group. Coenzyme Q10 significantly inhibited the elevation of sequestosome‐1, interleukin‐1β, oligomerization domain‐like receptor 3 and nucleotide‐binding, interleukin‐6, and tumor necrosis factor‐α expression levels; coenzyme Q10 also increased beclin 1 levels. Coenzyme Q10 might be a significant agent in the treatment of liver injury induced by sepsis.
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 3182919
Erratum to “Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice”
In the article titled “Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice” [1], Figure 1 contains an error where the image of the control group was duplicated in the image for the TQ+CLP group. This duplication was introduced during the production of the article, and the publisher apologises for this error. The corrected figure is shown below and is listed as Figure 1:
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 3182919
Open AccessErratum to “Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice”
In the article titled “Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice” [1], Figure 1 contains an error where the image of the control group was duplicated in the image for the TQ+CLP group. This duplication was introduced during the production of the article, and the publisher apologises for this error. The corrected figure is shown below and is listed as Figure 1:
- Open Access
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 1594726
Effect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice
Acute kidney injury (AKI) is a common complication of sepsis and has also been observed in some patients suffering from the new coronavirus pneumonia COVID‐19, which is currently a major global concern. Thymoquinone (TQ) is one of the most active ingredients in Nigella sativa seeds. It has a variety of beneficial properties including anti‐inflammatory and antioxidative activities. Here, we investigated the possible protective effects of TQ against kidney damage in septic BALB/c mice. Eight‐week‐old male BALB/c mice were divided into four groups: control, TQ, cecal ligation and puncture (CLP), and TQ+CLP. CLP was performed after 2 weeks of TQ gavage. After 48 h, we measured the histopathological alterations in the kidney tissue and the serum levels of creatinine (CRE) and blood urea nitrogen (BUN). We also evaluated pyroptosis (NLRP3, caspase‐1), apoptosis (caspase‐3, caspase‐8), proinflammatory (TNF‐α, IL‐1β, and IL‐6)‐related protein and gene expression levels. Our results demonstrated that TQ inhibited CLP‐induced increased serum CRE and BUN levels. It also significantly inhibited the high levels of NLRP3, caspase‐1, caspase‐3, caspase‐8, TNF‐α, IL‐1β, and IL‐6 induced by CLP. Furthermore, NF‐κB protein level was significantly decreased in the TQ+CLP group than in the CLP group. Together, our results indicate that TQ may be a potential therapeutic agent for sepsis‐induced AKI.
- 1 January 2020
- Published by Wiley in BioMed Research International
- Vol. 2020 (1) , 1594726
Open AccessEffect of Thymoquinone on Acute Kidney Injury Induced by Sepsis in BALB/c Mice
Acute kidney injury (AKI) is a common complication of sepsis and has also been observed in some patients suffering from the new coronavirus pneumonia COVID‐19, which is currently a major global concern. Thymoquinone (TQ) is one of the most active ingredients in Nigella sativa seeds. It has a variety of beneficial properties including anti‐inflammatory and antioxidative activities. Here, we investigated the possible protective effects of TQ against kidney damage in septic BALB/c mice. Eight‐week‐old male BALB/c mice were divided into four groups: control, TQ, cecal ligation and puncture (CLP), and TQ+CLP. CLP was performed after 2 weeks of TQ gavage. After 48 h, we measured the histopathological alterations in the kidney tissue and the serum levels of creatinine (CRE) and blood urea nitrogen (BUN). We also evaluated pyroptosis (NLRP3, caspase‐1), apoptosis (caspase‐3, caspase‐8), proinflammatory (TNF‐α, IL‐1β, and IL‐6)‐related protein and gene expression levels. Our results demonstrated that TQ inhibited CLP‐induced increased serum CRE and BUN levels. It also significantly inhibited the high levels of NLRP3, caspase‐1, caspase‐3, caspase‐8, TNF‐α, IL‐1β, and IL‐6 induced by CLP. Furthermore, NF‐κB protein level was significantly decreased in the TQ+CLP group than in the CLP group. Together, our results indicate that TQ may be a potential therapeutic agent for sepsis‐induced AKI.
- 1 June 2011
- Published by National Space Science Center, Chinese Academy of Sciences
- Vol. 32 (3) , 343-7
[Morphologic differentiation analysis for rounded caudal fin group of Oreonectes (Balitoridae) from China].
Morphological characteristics were compared between three recorded species of rounded caudal fin Oreonectes and specimens collected from Guan'an of Guangxi. The results showed the Oreonectes sp. from Guan'an was distinguished from O. anphthalmus. Although some morphologic differentiations existed among Oreonectes sp., O. polystigmus, and O. platycephalus, their differentiations were not enough to distinguish between them. Consequently, we used multivariate morphometrics to determine their morphologic differentiation. Twenty-six frame characteristics and 20 general characteristics of 63 specimens were measured. The results of the Principal Component Analysis showed that Oreonectes sp. and O. polystigmus, and Oreonectes sp. and O. platycephalus occupied obviously different areas in the scatter plot. It is suggested that the specimens collected from Guan'an may be a cryptic new species of Oreonectes. However, its taxonomic status should be decided by evidence from anatomical and molecular biological studies.
- 1 June 2011
- Published by National Space Science Center, Chinese Academy of Sciences
- Vol. 32 (3) , 343-7
[Morphologic differentiation analysis for rounded caudal fin group of Oreonectes (Balitoridae) from China].
Morphological characteristics were compared between three recorded species of rounded caudal fin Oreonectes and specimens collected from Guan'an of Guangxi. The results showed the Oreonectes sp. from Guan'an was distinguished from O. anphthalmus. Although some morphologic differentiations existed among Oreonectes sp., O. polystigmus, and O. platycephalus, their differentiations were not enough to distinguish between them. Consequently, we used multivariate morphometrics to determine their morphologic differentiation. Twenty-six frame characteristics and 20 general characteristics of 63 specimens were measured. The results of the Principal Component Analysis showed that Oreonectes sp. and O. polystigmus, and Oreonectes sp. and O. platycephalus occupied obviously different areas in the scatter plot. It is suggested that the specimens collected from Guan'an may be a cryptic new species of Oreonectes. However, its taxonomic status should be decided by evidence from anatomical and molecular biological studies.
- 1 March 2010
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 21 (3) , 237-246
Zinc supplementation partially prevents renal pathological changes in diabetic rats
- 1 March 2010
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 21 (3) , 237-246
Zinc supplementation partially prevents renal pathological changes in diabetic rats